scispace - formally typeset
W

Wim Terryn

Researcher at Ghent University Hospital

Publications -  24
Citations -  920

Wim Terryn is an academic researcher from Ghent University Hospital. The author has contributed to research in topics: Fabry disease & Kidney disease. The author has an hindex of 13, co-authored 20 publications receiving 718 citations. Previous affiliations of Wim Terryn include Baylor College of Medicine.

Papers
More filters
Journal ArticleDOI

Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document

TL;DR: In this article, the authors defined European consensus recommendations for the initiation and cessation of Enzyme Replacement Therapy (ERT) in patients with Fabry disease, which may halt or attenuate disease progression.
Journal ArticleDOI

Delayed graft function in renal transplantation.

TL;DR: The main processes involved in delayed graft function are reviewed as they relate to five chronologically related stages: donor tissue quality, brain death and related stress, preservation variables, immune factors, and recipient variables.
Journal ArticleDOI

Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice

TL;DR: It is unclear whether enzyme replacement therapy (ERT) prevents deterioration of kidney function, and the low likelihood that a sufficiently powered randomized controlled trial on this topic will be performed, data of all patients with FD should be collected in a central registry.
Journal ArticleDOI

IRF2BPL Is Associated with Neurological Phenotypes.

Paul C. Marcogliese, +207 more
TL;DR: The results show that IRF2BPL and pits are required in the nervous system in humans and flies, and their loss leads to a range of neurological phenotypes in both species.